Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 254.34M | 248.69M | 225.18M | 146.12M | 23.43M | 31.20M |
Gross Profit | 62.14M | 58.92M | 42.12M | 22.27M | 2.33M | 4.70M |
EBITDA | -18.16M | -27.96M | -68.12M | -69.87M | -9.63M | -11.07M |
Net Income | -18.98M | -27.31M | -56.08M | -27.26M | -10.16M | -10.84M |
Balance Sheet | ||||||
Total Assets | 257.92M | 256.68M | 294.94M | 325.02M | 17.71M | 276.26M |
Cash, Cash Equivalents and Short-Term Investments | 113.42M | 127.14M | 166.14M | 194.04M | 12.16M | 276.26M |
Total Debt | 8.84M | 9.32M | 24.52M | 18.33M | 1.89M | 0.00 |
Total Liabilities | 34.82M | 34.74M | 60.64M | 50.54M | 6.63M | 0.00 |
Stockholders Equity | 223.10M | 221.94M | 234.30M | 274.49M | 11.08M | 0.00 |
Cash Flow | ||||||
Free Cash Flow | -19.55M | -35.51M | -34.46M | -37.86M | -11.20M | -11.16M |
Operating Cash Flow | 1.29M | -2.52M | -32.35M | -37.13M | -10.82M | -10.30M |
Investing Cash Flow | 40.42M | -1.02M | 17.09M | 79.34M | -377.00K | -1.05M |
Financing Cash Flow | -9.99M | -5.76M | -76.00K | -1.08M | 1.18M | 116.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $2.66B | 15.28 | 15.18% | 3.69% | 0.27% | 26.17% | |
55 Neutral | $336.59M | ― | -8.39% | ― | 6.70% | 63.35% | |
54 Neutral | $279.65M | 28.86 | 26.01% | ― | ― | ― | |
53 Neutral | $47.31M | ― | -378.73% | ― | -14.62% | -86.07% | |
50 Neutral | $1.26B | ― | -2416.94% | ― | -20.21% | 88.09% | |
47 Neutral | $189.72M | ― | 138.02% | ― | -3.95% | 85.63% | |
41 Neutral | $8.25M | ― | -398.23% | ― | -9.49% | 97.34% |
On August 1, 2025, Blade Air Mobility entered into an agreement to sell its passenger division to Joby Aviation for up to $125 million. This transaction will allow Blade to focus on its medical services division, which will be rebranded as Strata Critical Medical, emphasizing its logistics and medical services. The divestiture is expected to be financially neutral and will enable Blade, now Strata, to access Joby’s eVTOL aircraft for medical transport, enhancing its service offerings. The management transition will see Rob Wiesenthal moving to Joby, while Will Heyburn and Melissa Tomkiel will become co-CEOs of Strata.
The most recent analyst rating on (BLDE) stock is a Buy with a $6.50 price target. To see the full list of analyst forecasts on Blade Air Mobility stock, see the BLDE Stock Forecast page.